Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Person-First Support Drives Better Recovery and Return-to-Work Results
Mental health isn’t a side note in workers’ comp anymore.
Workers' Comp
Article
Ask The Pharmacist: What Adjusters Need to Know About Trubrexa, a High-Cost Topical Analgesic
Are private-label topicals like Trubrexa worth the cost in workers’ comp? Private label topical analgesics (PLTAs) continue to push p
Mitchell
News Release
Mitchell Expands Canadian Alternate Parts Network with the Addition of New Suppliers
Live pricing and inventory data from seven of the country’s leading recycled parts providers is now available from within Mitchell Cloud Estim
Workers' Comp
Article
Close More Files at Year End with Field Case Management
As the year winds down, inboxes fill up, providers take time off, and everyone wants to know when the claim will close.
WorkcompWire
Article
Understanding and Cultivating Resilience in the Workplace
Workers' Comp
Case Study